CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,096,127 | -26.8% | 26,965 | +17.6% | 0.18% | -22.0% |
| Q3 2022 | $1,498,000 | -7.8% | 22,920 | -14.3% | 0.23% | +58.7% |
| Q2 2022 | $1,625,000 | +204.9% | 26,738 | +214.6% | 0.14% | +210.9% |
| Q1 2022 | $533,000 | -39.8% | 8,499 | +7.5% | 0.05% | -28.1% |
| Q3 2021 | $885,000 | +9.1% | 7,906 | +49.2% | 0.06% | +16.4% |
| Q4 2020 | $811,000 | +243.6% | 5,300 | +64.9% | 0.06% | +243.8% |
| Q2 2020 | $236,000 | – | 3,215 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |